The following warnings have been issued so far

• Product warning: "CBD CARTRIDGE, Bedtime" and "CBD CARTRIDGE, Energize" for electronic cigarettes
  The "CBD CARTRIDGE, BEDTIME" (liquid in a cartridge for an electronic cigarette) contains 37.3 per cent oil. If this oil enters the lungs when inhaled, it can lead to serious respiratory diseases. The product therefore contains an ingredient that poses a risk to human health. We expressly warn against its use.
  The "CBD CARTRIDGE, Energize" (liquid in a cartridge for an electronic cigarette) contains 39.8 per cent oil. If this oil enters the lungs when inhaled, it can lead to serious respiratory diseases. The product therefore contains an ingredient that poses a risk to human health. We expressly warn against its use.
  OTS0155, 17.06.2024
• Product warning: "CBD CARTRIDGE, Relax" for electronic cigarette
  The "CBD liquid in a cartridge for an electronic cigarette contains 54.8 per cent oil. If this oil enters the lungs when inhaled, it can lead to serious respiratory diseases. The product therefore contains an ingredient that poses a risk to human health. We expressly warn against its use.
  OTS0145, 24.05.2024
• Product warning: electronic cigarette "CBDAY Vape Pen 50 % CBD"
  Health risk due to oil contained
  This liquid-filled electronic cigarette contains 98 % oil, which can lead to severe respiratory diseases if inhaled. The product therefore contains an ingredient that poses a risk to human health. We expressly warn against its use.
  OTS0084, 30.11.2020
• Product warning: "Happease Jungle Spirit Banana Kush" liquid for e-cigarettes
  Classification as a risk to human health according to § 10b Abs. 7 Z 5 TNRSG
  Product may cause serious respiratory diseases if inhaled.
  This liquid for e-cigarettes contains oil (glycerol tricaprylate), which may cause serious respiratory diseases if inhaled. The product has been assessed as a risk to human health and its use is expressly warned against.
  OTS0160, 28.02.2020

Due to the amendment of the New Psychoactive Substances Ordinance (NPSV), which came into force on 23 March 2023, the cannabinomimetic compound hexahydrocannabinol (HHC) - regardless of whether it was produced fully synthetically or semi-synthetically - is to be classified as a New Psychoactive Substance according to Schedule II. Therefore, the sale of any HHC products (incl. residual stocks) is prohibited in Austria.

Hexahydrocannabinol (HHC) is a psychoactive substance that has recently been increasingly entering the market in Austria and Europe. There was the potential of a large demand for HHC products by consumers in Austria and Europe. This includes existing cannabis users, but also new (including young and inexperienced) users who could have been attracted by its effects and its status as a "legal high".

Therefore, the inclusion of HHC in the New Psychoactive Substances Ordinance (NPSV) will prevent the trade in these psychoactive products, which were previously put on the market without any quality control, without criminalising consumers.

The possession of HHC products is not made punishable by this amendment. However, it is a criminal offence to put such products on the market contrary to the penal provision of § 4 of the New Psychoactive Substances Act (NPSG).

Economic compensation for remaining stocks is not provided for by law.

Office for Tobacco Coordination

• E-mail:
  tabak@ages.at
• Phone:
  +43 5 0555-25614
  or
  +43 5 0555-34837
• Address:
  Spargelfeldstraße 191
  1220 Vienna